Press Room
Press Releases
Cohera Medical, Inc.® is working to improve patient care by fulfilling the clinical need for strong, safe tissue adhesives. Our products are based on a unique chemical design that generates a very strong bond and is biocompatible for internal use. The basic chemistry can be formulated for a wide variety of surgical applications, including plastic, colorectal, orthopaedic and general surgery.
May 14, 2013
Cohera Medical, Inc. Brings Hope to Easier Healing Following Mastectomy Procedures with Innovative
TissuGlu® Surgical Adhesive Has the Potential to Eliminate Drains, Improving Patient Recovery
May 1, 2013
Cohera Medical, Inc® Is Named A 2013 Gold Edison Award Winner
Cohera Medical Wins at Chicago Ceremony; Awards Celebrate 26 Years of Honoring Innovators and Innovation
April 23, 2013
First Patient Treated in Study of Cohera Medical’s Sylys™ Surgical Sealant
Study to Investigate the Safety of Sylys in Colorectal Procedures
March 12, 2013
Cohera Medical, Inc® Receives Approval To Begin Human Clinical Trials Of Sylys™ Surgical Sealant
The study will investigate the safety and efficacy of Sylys, and its effect on leakage following bowel repair and associated complications in colorectal surgeries.
March 5, 2013
First Patient Treated in U.S. No-Drain Clinical Study of Cohera Medical’s TissuGlu®
Study Investigates the Use of TissuGlu in Abdominoplasty Surgeries, Eliminating Postoperative Drains.
February 19, 2013
Cohera Medical, Inc® Named Edison Awards Finalist
Cohera Medical has been named a 2013 Award Finalist by the internationally renowned Edison Awards™. TissuGlu by Cohera Medical is a Finalist in the Science/Medical – Surgical Aids category, one of twelve categories honored by the Edison Awards. The distinguished awards symbolize the persistence and excellence personified by Thomas Alva Edison, inspiring creative minds to remain in the forefront of innovation, creativity and ingenuity in the global economy.
February 15, 2013
Cohera Medical, Inc.® Raises $17 Million in Series D Round
Cohera Medical, Inc.® has secured $17 million towards Series D financing through private investors. The milestone comes from raising an additional $7.3 million in the Company’s latest offering, in addition to the $9.7 million raised in 2012.
January 31, 2013
Cohera Medical Named Winner of 2013 Carnegie Science Award
Patrick Daly, CEO, to Receive Honor in Start-Up Entrepreneur Category for Outstanding Science and Technology Innovation in Western PA